bexlosteride
{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477372371
| IUPAC_name = (4aR,10bR)-8-Chloro-4-methyl-1,4,4a,5,6,10b-hexahydrobenzo[f]quinolin-3(2H)-one
| image = Bexlosteride.svg
| tradename =
| pregnancy_category =
| legal_status = Uncontrolled
| routes_of_administration = Oral
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 148905-78-6
| ATC_prefix = none
| ATC_suffix =
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 24955
| PubChem = 166562
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 36X732P4P0
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 145762
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H16ClNO/c1-16-13-6-2-9-8-10(15)3-4-11(9)12(13)5-7-14(16)17/h3-4,8,12-13H,2,5-7H2,1H3/t12-,13-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WQBIOEFDDDEARX-CHWSQXEVSA-N
| synonyms = LY 300502
| C=14 | H=16
| Cl=1 | N=1
| O=1
| smiles = CN1[C@@H]2CCc3cc(ccc3[C@H]2CCC1=O)Cl
}}
Bexlosteride is a potent and noncompetitive inhibitor of the enzyme 5α-reductase related to finasteride and dutasteride.{{Cite book | vauthors = Chang C | title = Androgens and androgen receptor : mechanisms, functions, and clinical application | date = 2002 | publisher = Kluwer Academic Publishers | location = Boston | isbn = 1-4020-7188-4 | url = https://books.google.com/books?id=ODBLQc2BdDIC&q=Bexlosteride&pg=PA167}}{{cite book | vauthors = Lednicer D | title = Strategies for Organic Drug Synthesis and Design | publisher = Wiley-Interscience | location = New York | year = 2008 | isbn = 978-0-470-19039-5 | url = https://books.google.com/books?id=fEwl6Qev-mUC&q=Bexlosteride&pg=PA208}} It is selective for the type I isoform of the enzyme. It advanced to Phase III clinical trials, but development was halted at that stage, and it was never marketed.{{cite web | url = http://adisinsight.springer.com/drugs/800009929 | title = Drug Profile: Bexlosteride| publisher = Adis Insight}}Reaxys entry for bexlosteride: Reaxys Registry Number: 6635310
See also
References
{{Reflist}}
{{Drugs used in benign prostatic hypertrophy}}
{{Other dermatological preparations}}
{{Androgenics}}